Insmed Inc. (INSM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insmed Inc. (INSM)

INSM 189.60

-2.4%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	1/7/2006 6:05:53 AM
	Read Replies (1) of 136

waiting to hear: January 2006: Competitor Tercica’s launch of Increlex for severe primary IGFD January 2006: Private mediation scheduled for patent infringement case vs. Tercica 2Q06: Insmed’s launch of iPlex for same indication as above 2H06: Response from EMEA on Tercica’s Increlex MAA filing in Europe November 2006: Jury trial on patent litigation against Tercica, if no settlement or summary judgement still no diabetes info, so staying out for now...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next